Survival of Patients With MBD4-Mutated Metastatic Uveal Melanoma Treated With Immune Checkpoint Inhibitors.

Honoré N, Sanchez R, Piperno-Neumann S, Pierron G, Le Ven A, Houy A, Servois V, Vincent-Salomon A, Mariani P, Cassoux N, Matet A, Ramtohul T, Colas C, Rodrigues M

Open source

DOI
10.1167/tvst.15.9.19
Published
2026 Sep 1
Container
Translational vision science & technology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1167/tvst.15.9.19,
  title = {Survival of Patients With MBD4-Mutated Metastatic Uveal Melanoma Treated With Immune Checkpoint Inhibitors.},
  author = {Honoré N and Sanchez R and Piperno-Neumann S and Pierron G and Le Ven A and Houy A and Servois V and Vincent-Salomon A and Mariani P and Cassoux N and Matet A and Ramtohul T and Colas C and Rodrigues M},
  year = {2026},
  journal = {Translational vision science \& technology},
  doi = {10.1167/tvst.15.9.19},
  url = {https://doi.org/10.1167/tvst.15.9.19}
}

RIS

TY  - JOUR
TI  - Survival of Patients With MBD4-Mutated Metastatic Uveal Melanoma Treated With Immune Checkpoint Inhibitors.
AU  - Honoré N
AU  - Sanchez R
AU  - Piperno-Neumann S
AU  - Pierron G
AU  - Le Ven A
AU  - Houy A
AU  - Servois V
AU  - Vincent-Salomon A
AU  - Mariani P
AU  - Cassoux N
AU  - Matet A
AU  - Ramtohul T
AU  - Colas C
AU  - Rodrigues M
PY  - 2026
JO  - Translational vision science & technology
DO  - 10.1167/tvst.15.9.19
UR  - https://doi.org/10.1167/tvst.15.9.19
ER  - 

APA

N, H., R, S., S, P., G, P., A, L. V., A, H., V, S., A, V., P, M., N, C., A, M., T, R., C, C., & M, R. (2026). Survival of Patients With MBD4-Mutated Metastatic Uveal Melanoma Treated With Immune Checkpoint Inhibitors.. Translational vision science & technology. https://doi.org/10.1167/tvst.15.9.19

Source records